Real-world data can be used to compare efficacy of MS treatments
Real-world data collected from a registry can be used to reliably compare the effectiveness of different multiple sclerosis (MS) treatments, so long as appropriate methodologies are employed to account for the messiness ā what researchers call confounding bias ā of real-world data, according to a new study. While registries…